feed,title,long_url,short_url
Benzinga,New Reimbursement Rules For Diagnostic Radiopharmaceuticals Is 'Undoubtedly' Positive for Lantheus: Analyst,https://benzinga.com/analyst-ratings/analyst-color/24/07/39717130/new-reimbursement-rules-for-diagnostic-radiopharmaceuticals-is-undoubtedly-positive,https://da.gd/AAB4no
